Gawor K, Tome S, Vandenberghe R, Van Damme P, Vandenbulcke M, Otto M
Brain Commun. 2024; 6(6):fcae442.
PMID: 39659977
PMC: 11631359.
DOI: 10.1093/braincomms/fcae442.
Jiang L, Zhang X, Hu H
Int J Mol Sci. 2024; 25(22).
PMID: 39596445
PMC: 11594478.
DOI: 10.3390/ijms252212380.
Lee R, Koh T
Oxf Open Neurosci. 2024; 2:kvad001.
PMID: 38596238
PMC: 10913850.
DOI: 10.1093/oons/kvad001.
Walker L, Attems J
J Parkinsons Dis. 2023; 14(1):35-52.
PMID: 38143370
PMC: 10836576.
DOI: 10.3233/JPD-230154.
Han Y, He Z
Front Aging Neurosci. 2023; 15:1189809.
PMID: 37181621
PMC: 10174460.
DOI: 10.3389/fnagi.2023.1189809.
mutations in a cohort of Italian patients with Parkinson's disease and atypical parkinsonisms.
Tiloca C, Goldwurm S, Calcagno N, Verde F, Peverelli S, Calini D
Front Aging Neurosci. 2022; 14:1020948.
PMID: 36247987
PMC: 9557978.
DOI: 10.3389/fnagi.2022.1020948.
Synucleinopathy in Amyotrophic Lateral Sclerosis: A Potential Avenue for Antisense Therapeutics?.
Roberts B, Theunissen F, Mastaglia F, Akkari P, Flynn L
Int J Mol Sci. 2022; 23(16).
PMID: 36012622
PMC: 9409035.
DOI: 10.3390/ijms23169364.
Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease.
Uemura M, Robinson J, Cousins K, Tropea T, Kargilis D, McBride J
Acta Neuropathol. 2021; 143(1):15-31.
PMID: 34854996
PMC: 9136643.
DOI: 10.1007/s00401-021-02383-3.
Autophagy and ALS: mechanistic insights and therapeutic implications.
Chua J, de Calbiac H, Kabashi E, Barmada S
Autophagy. 2021; 18(2):254-282.
PMID: 34057020
PMC: 8942428.
DOI: 10.1080/15548627.2021.1926656.
Prion-like C-Terminal Domain of TDP-43 and α-Synuclein Interact Synergistically to Generate Neurotoxic Hybrid Fibrils.
Dhakal S, Wyant C, George H, Morgan S, Rangachari V
J Mol Biol. 2021; 433(10):166953.
PMID: 33771571
PMC: 8085152.
DOI: 10.1016/j.jmb.2021.166953.
Nuclear Envelope and Nuclear Pore Complexes in Neurodegenerative Diseases-New Perspectives for Therapeutic Interventions.
Hachiya N, Sochocka M, Brzecka A, Shimizu T, Gasiorowski K, Szczechowiak K
Mol Neurobiol. 2020; 58(3):983-995.
PMID: 33067781
PMC: 7878205.
DOI: 10.1007/s12035-020-02168-x.
TDP-43 prevents retrotransposon activation in the Drosophila motor system through regulation of Dicer-2 activity.
Romano G, Klima R, Feiguin F
BMC Biol. 2020; 18(1):82.
PMID: 32620127
PMC: 7334854.
DOI: 10.1186/s12915-020-00816-1.
A multi-faceted genotoxic network of alpha-synuclein in the nucleus and mitochondria of dopaminergic neurons in Parkinson's disease: Emerging concepts and challenges.
Vasquez V, Mitra J, Wang H, Hegde P, Rao K, Hegde M
Prog Neurobiol. 2019; 185:101729.
PMID: 31863801
PMC: 7098698.
DOI: 10.1016/j.pneurobio.2019.101729.
Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis.
Prasad A, Bharathi V, Sivalingam V, Girdhar A, Patel B
Front Mol Neurosci. 2019; 12:25.
PMID: 30837838
PMC: 6382748.
DOI: 10.3389/fnmol.2019.00025.
Pathomechanisms of TDP-43 in neurodegeneration.
Gao J, Wang L, Huntley M, Perry G, Wang X
J Neurochem. 2018; .
PMID: 29486049
PMC: 6110993.
DOI: 10.1111/jnc.14327.
Drosophila lines with mutant and wild type human TDP-43 replacing the endogenous gene reveals phosphorylation and ubiquitination in mutant lines in the absence of viability or lifespan defects.
Chang J, Morton D
PLoS One. 2017; 12(7):e0180828.
PMID: 28686708
PMC: 5501610.
DOI: 10.1371/journal.pone.0180828.
Quantification of the Relative Contributions of Loss-of-function and Gain-of-function Mechanisms in TAR DNA-binding Protein 43 (TDP-43) Proteinopathies.
Cascella R, Capitini C, Fani G, Dobson C, Cecchi C, Chiti F
J Biol Chem. 2016; 291(37):19437-48.
PMID: 27445339
PMC: 5016682.
DOI: 10.1074/jbc.M116.737726.
From animal models to human disease: a genetic approach for personalized medicine in ALS.
Picher-Martel V, Valdmanis P, Gould P, Julien J, Dupre N
Acta Neuropathol Commun. 2016; 4(1):70.
PMID: 27400686
PMC: 4940869.
DOI: 10.1186/s40478-016-0340-5.
Disease animal models of TDP-43 proteinopathy and their pre-clinical applications.
Liu Y, Chiang P, Tsai K
Int J Mol Sci. 2013; 14(10):20079-111.
PMID: 24113586
PMC: 3821604.
DOI: 10.3390/ijms141020079.
Overexpression of ALS-associated p.M337V human TDP-43 in mice worsens disease features compared to wild-type human TDP-43 mice.
Janssens J, Wils H, Kleinberger G, Joris G, Cuijt I, Ceuterick-de Groote C
Mol Neurobiol. 2013; 48(1):22-35.
PMID: 23475610
PMC: 3718993.
DOI: 10.1007/s12035-013-8427-5.